COPD and Asthma Device Market 2022 Industry Analysis, Key Drivers, Business Strategy, Opportunities and Forecast to 2030

SDKI Inc. published a new research report on the Global COPD and Asthma Device Market-Forecast 2022-2030. The report provides a complete assessment of the market and its growth prospects, along with new business opportunities in the industry. It also includes market size and annual growth during the 2022-2030 forecast period.

Report sample URL
https://www.sdki.jp/sample-request-59038

The COPD and asthma device market is estimated to reach US $ 53.90 billion by 2030 from a market value of US $ 41.04 billion in 2022 and is expected to grow at a CAGR of 4.3% during the 2022-2030 forecast period. increase.

Chronic obstructive pulmonary disease (COPD) and asthma devices are for respiratory diseases Permanent treatment or salvage therapy. COPD and asthma are respiratory diseases that cause dyspnea and obstruction of the airways of the lungs due to inflammation, mucus production, and muscle tightening. Daily exposure to environmental pollution and portability of drug delivery devices are key factors driving the growth of the COPD and asthma device market during the forecast period. The growing population of active smokers and the growing government initiative for COPD and asthma devices are also contributing to the growth of the COPD and asthma device market.

According to the International Respiratory Society (FIRS) forum, about 384 million people suffer from chronic obstructive pulmonary disease (COPD) and 3 million die each year. Therefore, it is the third leading cause of death in the world. In addition, the government's initiative to increase the prevalence of respiratory diseases such as COPD, asthma, and emphysema, the need for first aid during sudden asthma attacks, and the awareness of COPD and asthma symptoms. , Creates favorable growth opportunities for this market. However, intensifying price competition, poor material quality, and the overall high cost of asthma treatment could curb the growth of the global COPD and asthma device markets during the forecast period.

Global market growth can be attributed to various significant advances in the healthcare industry to promote health through the development of three basic parameters: detection, prevention, and treatment. These parameters are needed to measure health, quality of life, and the overall health system. In addition, rising medical costs are driving market growth. According to the Organization for Economic Co-operation and Development (OECD) statistics, Japan's total per capita health care costs (government, compulsory health insurance, voluntary health insurance) increased from US $ 4297.13 in 2016 to US $ 4823 in 2019. Similarly, in the United States, it increased from $ 9880.16 to $ 11072 in 2019. Germany has witnessed an increase from $ 5668 to $ 6646, and the United Kingdom has observed growth from $ 3990 to $ 4653.05 during the above period. Globally, healthcare costs are projected to grow at a CAGR of approximately 5% between 2020 and 2024.

Sample URL of the report
https://www.sdki.jp/sample-request-59038

Advances in the healthcare sector are estimated to provide lucrative business opportunities for key players to take advantage of these opportunities in the coming years. In addition, there are several initiatives taken by healthcare professionals and government agencies to overcome some challenges (unreachable and affordable medical services, lack of investment in health care, trained doctors and nurses, etc.). It is expected to boost market growth during the forecast period.

COPD and asthma device market segment

The COPD and asthma device market is divided by product type (inhalers and nebulizers), indications (asthma and chronic obstructive pulmonary disease (COPD)), distribution channels (retail pharmacies, hospitals, online pharmacies) and regions. increase. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Regional Overview of the COPD and Asthma Device Market

In addition, the report covers all regions of the world, divided into North America, Europe, Asia Pacific, Latin America, Middle East & Africa and more. The North American region is a major region of the world during the forecast period. This is due to the widespread and early adoption of inhalers and nebulizers, as well as the large pool of patients suffering from respiratory illness. Meanwhile, the Asia Pacific COPD and asthma device markets are expected to witness the highest growth rates during the forecast period (2022-2030). This growth is due to increased medical costs, increased awareness of highly portable COPD and asthma devices, and increased disposable income.

Details of the survey report
https://www.sdki.jp/press-details/global-copd-and-asthma-devices-market/45

Key players in the COPD and asthma device market

Key Players in the COPD and asthma device market include Aerogen, Inc., AstraZeneca PLC, Baxter International Inc., Boehringer Ingelheim International GmbH, 3M COMPANY, GF Health Products, GlaxoSmithKline Plc , Koninklijke Philips NV, Novartis AG, PARI medical Holding GMBH, Smith's Group Plc. The study includes a detailed competitive analysis of these major companies in the COPD and asthma device markets, corporate profiles, recent developments, and key market strategies.

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.